A. Goate
Physiology · 2011–2023
A researcher in the Science corpus: 12 papers; trusts 4 researchers and is trusted by 2 researchers here, as inferred from the citation graph.
Subfields
- Physiology — 151 citations into it; #892 of 2,276 by trust here, #101 by citations
- Molecular Biology — 107 citations into it
- Psychiatry and Mental health — 61 citations into it
- Neurology — 45 citations into it; #662 of 1,455 by trust here, #147 by citations
Whom A. Goate trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts A. Goate overall
Papers from A. Goate's perspective
Ordered by how strongly the researchers A. Goate trusts endorse each paper. Same corpus, a different order for every researcher.
- Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. (Archives of Neurology)
- ApoE promotes the proteolytic degradation of Abeta. (Neuron)
- Siglecs and their roles in the immune system (Nature reviews. Immunology)
- Neuropathological stageing of Alzheimer-related changes
- Human amyloid-β synthesis and clearance rates as measured in cerebrospinal fluid in vivo (Nature Medicine)
- apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. (Journal of Clinical Investigation)
- Control of Peripheral Nerve Myelination by the ß-Secretase BACE1 (Science)
- Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. (Lancet Neurology)
- Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. (Proceedings of the National Academy of Sciences of the United States of America)
- The National Alzheimer's Coordinating Center (NACC) Database: The Uniform Data Set (Alzheimer Disease and Associated Disorders)
Their papers
- Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease (2013) — 4,257 citations
- Human apoE isoforms differentially regulate brain amyloid-β peptide clearance (2011) — 1,198 citations
- Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease (2011) — 1,887 citations
- Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies LRRC4C, LHX5-AS1 and nominates ancestry-specific loci PTPRK, GRB14, and KIAA0825 as novel risk loci for Alzheimer disease: the Alzheimer Disease Genetics Consortium (2023) — 1,168 citations
- Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease (2019) — 781 citations
- Alzheimer's disease risk genes and mechanisms of disease pathogenesis (2014) — 1,238 citations
- Gene-Wide Analysis Detects Two New Susceptibility Genes for Alzheimer's Disease (2014) — 1,239 citations
- Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease (2013) — 1,348 citations
- TREM2 Variants in Alzheimer's Disease (2012) — 2,718 citations
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer’s Disease (2012) — 3,500 citations
- Alzheimer’s Disease: The Challenge of the Second Century (2011) — 1,386 citations
- Common variants in ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease (2011) — 1,932 citations